European Journal of Cancer
Volume 46, Issue 1 , Pages 207-215 , January 2010

Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion

  • Manoj Garg

      Affiliations

    • National Institute of Immunology, New Delhi, India
    • ,
  • Deepika Kanojia

      Affiliations

    • National Institute of Immunology, New Delhi, India
    • ,
  • Amlesh Seth

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Rajive Kumar

      Affiliations

    • Institute of Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Anju Gupta

      Affiliations

    • Department of Pathology, Moolchand Hospital, New Delhi, India
    • ,
  • Avadhesha Surolia

      Affiliations

    • National Institute of Immunology, New Delhi, India
    • ,
  • Anil Suri

      Affiliations

    • National Institute of Immunology, New Delhi, India
    • Corresponding Author InformationCorresponding author: Address: Cancer Research Program, Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110 067, India. Tel.: +91 11 26703 700; fax: +91 11 26 1621 25.

Received 24 July 2009 ,Accepted 15 October 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Sternberg CN. The treatment of advanced bladder cancer. Ann Oncol. 1995;6:113–126
  3. Kawanishi H, Matsui Y, Ito M, et al. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res. 2008;14:2579–2587
  4. Juffs HG, Moore MJ, Tannock IF. The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. Lancet Oncol. 2002;3:738–747
  5. Hendrick JP, Hart FU. Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 1993;62:349–384
  6. Rohde M, Daugaard M, Jensen MH, et al. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev. 2005;19:570–582
  7. Jaattela M. Heat shock proteins as cellular lifeguards. Ann Med. 1999;31:261–271
  8. Volloch VZ, Sherman MY. Oncogenic potential of Hsp72. Oncogene. 1999;18:3648–3651
  9. Gurbuxani S, Bruey JM, Fromentin A, et al. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene. 2001;20:7478–7485
  10. Wei YQ, Zhao X, Kariya Y, Teshigawara K, Uchida A. Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunol Immunother. 1995;40:73–78
  11. Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res. 2002;62:7139–7142
  12. Son WY, Hwang SH, Han CT, et al. Specific expression of heat shock protein HspA2 in human male germ cells. Mol Hum Reprod. 1999;5:1122–1126
  13. Fourie AM, Peterson PA, Yang Y. Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2. Cell Stress Chaperones. 2001;6:282–295
  14. Zhu D, Dix DJ, Eddy EM. HSP 70-2 is required for CDC2 kinase activity in meiosis I of mouse spermatocytes. Development. 1997;124:3007–3014
  15. Hahn WC, Weinberg RA. Rules for making human tumor cells. New Engl J Med. 2002;347:1593–1603
  16. Eble JN, Sauter G, Epstein JI, Sesterhenn IAE. World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004;
  17. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on cancer staging manual. 6th ed.. New York (NY): Springer; 2002;
  18. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest. 1994;71:583–594
  19. Garg M, Kanojia D, Khosla A, et al. Sperm associated antigen 9 is associated with tumor growth, migration and invasion in renal cell carcinoma. Cancer Res. 2008;68:8240–8248
  20. Garg M, Kanojia D, Salhan S, et al. Sperm-associated antigen 9 (SPAG9) is a biomarker for early cervical carcinoma. Cancer. 2009;115:2671–2683
  21. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res. 2007;13:1421–1428
  22. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:630–639
  23. Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol. 1983;130:1083–1086
  24. Shariat SF, Karam JA, Lerner SP. Molecular markers in bladder cancer. Curr Opin Urol. 2008;18:1–8
  25. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  26. Petricoin EF, Hackett JL, Lesko LJ, et al. Medical applications of microarray technologies: a regulatory science perspective. Nat Genet. 2002;32:474–479
  27. Takata R, Katagiri T, Kanehira M, et al. Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling. Clin Cancer Res. 2005;11:2625–2636
  28. Syrigos KN, Harrington KJ, Karayiannakis AJ, et al. Clinical significance of heat shock protein-70 expression in bladder cancer. Urology. 2003;613:677–680
  29. Xanthoudakis S, Nicholson DW. Heat-shock proteins as death determinants. Nat Cell Biol. 2000;2:E163–E165
  30. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med. 2004;200:425–435
  31. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Eng J Med. 2001;344:783–792
  32. Shin BK, Wang H, Yim AM, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem. 2003;278:7607–7616

PII: S0959-8049(09)00778-3

doi: 10.1016/j.ejca.2009.10.020

European Journal of Cancer
Volume 46, Issue 1 , Pages 207-215 , January 2010

Article Tools

* Image Usage & Resolution